-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Hold on Edwards Lifesciences, Raises Price Target to $82

Benzinga·07/25/2025 15:24:10
Listen to the news
Truist Securities analyst Richard Newitter maintains Edwards Lifesciences (NYSE:EW) with a Hold and raises the price target from $81 to $82.